Literature DB >> 10101953

Selective COX-2 inhibitors: is the water becoming muddy?

J L Wallace1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101953     DOI: 10.1016/s0165-6147(98)01283-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  13 in total

1.  Commonality of defensive roles of COX-2 in the lung and gut.

Authors:  John L Wallace
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.

Authors:  M Majima; I Hayashi; M Muramatsu; J Katada; S Yamashina; M Katori
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

4.  Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.

Authors:  M N Muscará; N Vergnolle; F Lovren; C R Triggle; S N Elliott; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  Polypharmacy of osteoarthritis: the perfect intestinal storm.

Authors:  John L Wallace
Journal:  Dig Dis Sci       Date:  2013-07-25       Impact factor: 3.199

6.  Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells.

Authors:  Elias G Awji; Hitendra Chand; Shannon Bruse; Kevin R Smith; Jennifer K Colby; Yohannes Mebratu; Bruce D Levy; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

Review 7.  mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".

Authors:  Masako Nakanishi; Vijay Gokhale; Emmanuelle J Meuillet; Daniel W Rosenberg
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

8.  Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria.

Authors:  Melanie J Stables; Justine Newson; Samir S Ayoub; Jeremy Brown; Catherine J Hyams; Derek W Gilroy
Journal:  Blood       Date:  2010-07-06       Impact factor: 22.113

Review 9.  COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

Authors:  Samir Malhotra; N Shafiq; P Pandhi
Journal:  MedGenMed       Date:  2004-03-23

10.  The impact of recent data on our understanding of the roles of COX-1 and COX-2 in gastrointestinal pathophysiology.

Authors:  Ingvar Bjarnason
Journal:  Clin Drug Investig       Date:  2007-12       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.